President and CEO
Object Pharma, Inc.
The startup develops botulinum neurotoxins for therapeutic applications, targeting specific muscle functions to provide relief for various medical conditions. Their products address the need for effective treatments in areas where traditional therapies are insufficient, enhancing patient outcomes through muscle function modulation.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops botulinum neurotoxins for therapeutic applications, targeting specific muscle functions to provide relief for various medical conditions. Their products address the need for effective treatments in areas where traditional therapies are insufficient, enhancing patient outcomes through muscle function modulation.